4
Changes in Ownership
Vaxcyte, Inc. Filed Acc 0001649094-24-000025
CHIEF EXECUTIVE OFFICER sold 2,616 shares at an average $76.33 ($199,690)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| PICKERING GRANT CHIEF EXECUTIVE OFFICER | 2024-07-01 | Sale 10b5-1 | −674 | $75.84 | $51,119 | 144,072 | I: show line 1 in the form |
| PICKERING GRANT CHIEF EXECUTIVE OFFICER | 2024-07-01 | Sale 10b5-1 | −634 | $76.86 | $48,728 | 143,438 | I: show line 2 in the form |
| PICKERING GRANT CHIEF EXECUTIVE OFFICER | 2024-07-01 | Sale 10b5-1 | −751 | $75.92 | $57,016 | 143,995 | I: show line 3 in the form |
| PICKERING GRANT CHIEF EXECUTIVE OFFICER | 2024-07-01 | Sale 10b5-1 | −557 | $76.89 | $42,826 | 143,438 | I: show line 4 in the form |
| Open-market sales · 2,616 sh · avg $76.33 · $199,690 | |||||||
Loading xslF345X05/wk-form4_1719951139.xml…